Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05081427 · ClinicalTrials.gov registry record
Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 17
- Enrollment target
NCT05081427: Completed study, sponsored by Mayo Clinic.
NCT05081427 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05081427 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study is a prospective, observational, single-center, short-term cross-sectional study to assess the repeatability and reproducibility of a set of specified MRI quantitative biomarkers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05081427
The ClinicalTrials.gov registry entry for NCT05081427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05081427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05081427 about?
NCT05081427 is a clinical study titled "Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2". This study is a prospective, observational, single-center, short-term cross-sectional study to assess the repeatability and reproducibility of a set of specified MRI quantitative biomarkers.
What is the current status of trial NCT05081427?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2021-11-15. Estimated completion is 2022-06-30.
Who is sponsoring clinical trial NCT05081427?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.